SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 8.13 |
Enterprise Value ($M) | 6.97 |
Book Value ($M) | 2.83 |
Book Value / Share | 0.45 |
Price / Book | 2.87 |
NCAV ($M) | 1.30 |
NCAV / Share | 0.21 |
Price / NCAV | 6.23 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.02 |
Return on Assets (ROA) | -0.40 |
Return on Equity (ROE) | -19.68 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.96 |
Current Ratio | 1.42 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 7.22 |
Assets | 8.75 |
Liabilities | 5.92 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Sternheim Eliezer | |||
13G/A | Armistice Capital, Llc | 4.99 | 4.84 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
26,591 | 140,080 | 18.98 | |
45,327 | 397,299 | 11.41 | |
42,491 | 127,454 | 33.34 | |
17,045 | 70,895 | 24.04 | |
(click for more detail) |
Similar Companies | |
---|---|
APTO – Aptose Biosciences Inc. | APVO – Aptevo Therapeutics Inc. |
ARTL – Artelo Biosciences, Inc. | ASRT – Assertio Holdings, Inc. |
ATNF – 180 Life Sciences Corp. |
Financial data and stock pages provided by
Fintel.io